SEC Form D filing

AdvanCell, Inc., 2026-07-16

An SEC Form D private-offering notice from Cambridge, MA, a $315,000,000 filer-stated offering target in Biotech. Filed 2026-07-16. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

AdvanCell, Inc. site↗ Verified via SEC Form D

Clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, with US headquarters in Cambridge, Massachusetts.

Filed 2026-07-16Filed to raise $315,000,000First money in 2026-06-30Raised so far $218,333,294HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified advancell.com.au↗Named in the filing 11 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source